Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Molecularly Defined Clonal Evolution in Patients with Chronic Myeloid Leukemia Independent of the BCR-ABL Status

Thomas Ernst, MD, Mathias Schmidt, Jenny Rinke, Vivien Schäfer, Anja Waldau, Ellen Obstfelder, Nils Winkelmann, MD, Janine Ziermann, PhD, Susanne Schnittger, PhD, Torsten Haferlach, MD PhD, Claudia Haferlach, MD, Andreas Hochhaus, MD

Blood (2014) 124 (21): 4513.

https://doi.org/10.1182/blood.V124.21.4513.4513

Published: 2014

Journal Articles

High Density SNP Array Analysis of Tyrosine Kinase Inhibitor (TKI) Resistant Chronic Myeloid Leukemia (CML) Shows Secondary Genomic Alterations

Daniel Nowak, MD, Norihiko Kawamata, MD, Tadayuki Akagi, PhD, Ryoko Okamoto, PhD, Nils Thoennissen, MD, Wolf-Karsten Hofmann, MD, PhD, Motohiro Kato, PhD, Torsten Haferlach, MD, PhD, Seishi Ogawa, MD, PhD, H. Phillip Koeffler, MD, PhD

Blood (2008) 112 (11): 3182.

https://doi.org/10.1182/blood.V112.11.3182.3182

Published: 2008

Journal Articles

Numerous Genomic Abnormalities in AML with Normal Karyotype.

Tadayuki Akagi, PhD, Seishi Ogawa, MD, Go Yamamoto, MD, Yasuhito Nannya, MD, Masashi Sanada, MD, Norihiko Kawamata, MD, Carl W. Miller, PhD, Martin Dugas, PhD, Susanne Schnittger, PhD, Torsten Haferlach, MD, PhD, Claudia Haferlach, MD, H. Phillip Koeffler, MD

Blood (2007) 110 (11): 1811.

https://doi.org/10.1182/blood.V110.11.1811.1811

Published: 2007

Journal Articles

Complete Hematologic Response to Sunitinib in an Eosinophilia-Associated Chronic Myeloproliferative Disorder with an ETV6-FLT3 Fusion Gene.

Christoph Walz, MD, Michael Ritter, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Christoph Schulte, MD, Torsten Haferlach, MD, PhD, Georgia Metzgeroth, MD, Rüdiger Hehlmann, MD, Andreas Hochhaus, MD, Nicholas C.P. Cross, PhD, Andreas Reiter, MD

Blood (2007) 110 (11): 3558.

https://doi.org/10.1182/blood.V110.11.3558.3558

Published: 2007

Journal Articles

Identification of Specific Genes Expression Signatures for CEBPa, NPM1 and FLT3 Genes Mutations in AML. A Study Based of the MILE Data Issued from 79 French Samples.

Christophe Roumier, MD, Olivier Nibourel, MD, John Devos, PHD, Pacale Cornillet-Lefebvre, MD, Sylvia Merk, PHD, Hervé Dombret, MD-PHD, Norbert Ifrah, MD-PHD, Elisabeth Macintyre, MD-PHD, Marie-Christine Bene, MD-PHD, Jean-Pierre Kerckaert, PHD, Torsten Haferlach, MD-PHD, Claude Preudhomme, PD-PHD

Blood (2007) 110 (11): 3481.

https://doi.org/10.1182/blood.V110.11.3481.3481

Published: 2007

NARROW

Molecularly Defined Clonal Evolution in Patients with Chronic Myeloid Leukemia Independent of the BCR-ABL Status

High Density SNP Array Analysis of Tyrosine Kinase Inhibitor (TKI) Resistant Chronic Myeloid Leukemia (CML) Shows Secondary Genomic Alterations

Numerous Genomic Abnormalities in AML with Normal Karyotype.

Complete Hematologic Response to Sunitinib in an Eosinophilia-Associated Chronic Myeloproliferative Disorder with an ETV6-FLT3 Fusion Gene.

Identification of Specific Genes Expression Signatures for CEBPa, NPM1 and FLT3 Genes Mutations in AML. A Study Based of the MILE Data Issued from 79 French Samples.

Email alerts

ASH Publications

American Society of Hematology

Molecularly Defined Clonal Evolution in Patients with Chronic Myeloid Leukemia Independent of the BCR-ABL Status

High Density SNP Array Analysis of Tyrosine Kinase Inhibitor (TKI) Resistant Chronic Myeloid Leukemia (CML) Shows Secondary Genomic Alterations

Numerous Genomic Abnormalities in AML with Normal Karyotype.

Complete Hematologic Response to Sunitinib in an Eosinophilia-Associated Chronic Myeloproliferative Disorder with an ETV6-FLT3 Fusion Gene.

Identification of Specific Genes Expression Signatures for CEBPa, NPM1 and FLT3 Genes Mutations in AML. A Study Based of the MILE Data Issued from 79 French Samples.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only